Corient Private Wealth’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Corient Private Wealth's ACLS Position: Q1 2026 in Review
Corient Private Wealth reduced its Axcelis (ACLS) stake by 51% in Q1 2026, selling an estimated $516K and leaving 5,595 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #2008.
Corient Private Wealth first reported a position in ACLS in Q1 2023 and has held it in 10 quarters since. The position peaked at $966K in Q2 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Corient Private Wealth held 5,595 shares of Axcelis worth $521K as of Q1 2026.
- Corient Private Wealth sold 5,824 Axcelis shares in Q1 2026, an estimated $516K.
- Axcelis made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2008 holding.
- Corient Private Wealth first reported a position in Axcelis in Q1 2023 and has held it in 10 quarters since.
- Corient Private Wealth's Axcelis position peaked at $966K in Q2 2024.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.